Top Midday Decliners

MT Newswires Live
03/25

Concentrix (CNXC) reported a decline in fiscal Q1 adjusted earnings Tuesday, which, along with its fiscal Q2 adjusted earnings per share forecast, missed analysts' estimates.

Shares slid nearly 24% as midday trading volume jumped to over 5.4 million shares from a daily average of about 1.3 million.

ImmunityBio (IBRX) shares dropped roughly 22% after the US Food and Drug Administration issued a warning letter citing "misleading" promotional materials for its bladder cancer drug Anktiva.

Trading volume stood at over 71.9 million shares, versus a daily average of roughly 37.3 million.

Lenz Therapeutics (LENZ) reported a Q4 net loss of $1.16 per diluted share, widening from a loss of $0.46 per share a year earlier.

Shares fell about 18%, with trading volume of 2.8 million shares against a daily average of about 954,000.

Price: 25.12, Change: -7.92, Percent Change: -23.97

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10